Legend Biotech Corporation (FRA:9LB)

Germany · Delayed Price · Currency is EUR

30.00

+8.40 (38.89%)

Last updated: Jun 3, 2026, 7:55 PM CET

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States of America Revenue	-	803.60M	579.05M
United States of America Revenue Growth	-	38.78%	114.55%
China Revenue	-	26.60M	320.00K
China Revenue Growth	-	8212.50%	78.77%
Europe Revenue	-	198.70M	47.87M
Europe Revenue Growth	-	315.06%	217.66%
Revenue (Total)	1.14B	1.03B	627.30M
Revenue (Total) Growth	10.68%	64.02%	120.03%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
License Revenue	81.12M	83.80M	138.40M
License Revenue Growth	-3.20%	-39.45%	293.64%
Collaboration Revenue	1.06B	944.80M	482.58M
Collaboration Revenue Growth	11.93%	95.78%	93.18%
Other Service Revenue	-	300.00K	6.26M
Other Service Revenue Growth	-	-95.20%	3395.53%
Revenue (Other)	121.00K	-	59.00K
Revenue (Total)	1.14B	1.03B	627.30M
Revenue (Total) Growth	10.68%	64.02%	120.03%

Updated Mar 31, 2026. Data Source: Fiscal.ai.